❌

Normal view

Received — 6 April 2026 ⏭ Oncogene - Issue - nature.com science feeds

Oncogene - Issue - nature.com science feeds
Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer Annabelle Lobermeyer · Jenna Sophie Schöllhorn · Paul N. Rademacher · Maximilian C. Wankner · Sandra Lenz · Cornelia Coith · Piet Sonnemann · Anna Jaeger · Leticia Oliveira-Ferrer · Linn Woelber · Sabine Riethdorf · Klaus Pantel · Barbara Schmalfeldt · Mina Netkova-Heintzen · Katharina Prieske · Simon A. Joosse
Oncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03747-3Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer
4 April 2026 at 08:00

Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer

Oncogene - Issue - nature.com science feeds

By: Annabelle Lobermeyer · Jenna Sophie Schöllhorn · Paul N. Rademacher · Maximilian C. Wankner · Sandra Lenz · Cornelia Coith · Piet Sonnemann · Anna Jaeger · Leticia Oliveira-Ferrer · Linn Woelber · Sabine Riethdorf · Klaus Pantel · Barbara Schmalfeldt · Mina Netkova-Heintzen · Katharina Prieske · Simon A. Joosse

4 April 2026 at 08:00

Oncogene, Published online: 04 April 2026; doi:10.1038/s41388-026-03747-3

Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer